Deficiency of Endothelial Cxcr4 Reduces Reendothelialization and Enhances Neointimal Hyperplasia After Vascular Injury in Atherosclerosis-Prone Mice
Author(s) -
Heidi Noels,
Baixue Zhou,
Pathricia V. Tilstam,
Wendy Theelen,
Xiaofeng Li,
Lukas Pawig,
Corinna Schmitz,
Shamima Akhtar,
Sakine Simsekyilmaz,
Erdenechimeg Shagdarsuren,
Andreas Schober,
Ralf H. Adams,
Jürgen Bernhagen,
Elisa A. Liehn,
Yvonne Döring,
Christian Weber
Publication year - 2014
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.113.302878
Subject(s) - neointima , neointimal hyperplasia , apolipoprotein e , chemokine , chemokine receptor , medicine , biology , endocrinology , inflammation , restenosis , disease , stent
The Cxcl12/Cxcr4 chemokine ligand/receptor axis mediates the mobilization of smooth muscle cell progenitors, driving injury-induced neointimal hyperplasia. This study aimed to investigate the role of endothelial Cxcr4 in neointima formation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom